Investigational Drugs Didn't Slow Cognitive Decline in Rare, Inherited Alzheimer's, Initial Analysis (IMAGE)

WashU Medicine

Investigational Drugs Didn't Slow Cognitive Decline in Rare, Inherited Alzheimer's, Initial Analysis

Caption

Randall J. Bateman, MD, of Washington University School of Medicine in St. Louis, led an international trial evaluating whether investigational drugs could slow memory loss and cognitive decline in a rare, inherited form of Alzheimer's disease. The trial was conducted at 24 sites in Australia, Canada, France, Spain, the United Kingdom and the United States.

Credit

Huy Mach/Washington University

Usage Restrictions

Credit to Washington University

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.